Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension

Antihypertensive efficacy of single‐pill combinations (SPCs) consisting of a β(1)‐selective adrenergic blocker with vasodilatory properties via β(3)‐agonism (nebivolol) and an angiotensin II receptor blocker (valsartan) was demonstrated in an 8‐week phase 3 trial (NCT01508026). In this post hoc anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Mende, Christian W., Giles, Thomas D., Bharucha, David B., Ferguson, William G., Mallick, Madhuja, Patel, Mehul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Therapetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484387/
https://www.ncbi.nlm.nih.gov/pubmed/28075064
http://dx.doi.org/10.1111/jch.12965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484387/
https://www.ncbi.nlm.nih.gov/pubmed/28075064
http://dx.doi.org/10.1111/jch.12965

Ejemplares similares